BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ochoa-Callejero L, García-Sanmartín J, Villoslada-Blanco P, Íñiguez M, Pérez-Matute P, Pujadas E, Fowkes ME, Brody R, Oteo JA, Martínez A. Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients. J Endocr Soc 2021;5:bvaa199. [PMID: 33506161 DOI: 10.1210/jendso/bvaa199] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Mukerjee N, Al-Hamash SMJ, Al-Maiahy TJ, Batiha GE. 5-HT/CGRP pathway and Sumatriptan role in Covid-19. Biotechnol Genet Eng Rev 2022;:1-26. [PMID: 36042570 DOI: 10.1080/02648725.2022.2108996] [Reference Citation Analysis]
2 Klimov V, Cherevko N, Klimov A, Novikov P. Neuronal-Immune Cell Units in Allergic Inflammation in the Nose. IJMS 2022;23:6938. [DOI: 10.3390/ijms23136938] [Reference Citation Analysis]
3 Ouerdane Y, Khlidj Y, Attia MS, Korissi R. Calcitonin gene-related peptide: A biomarker for stroke in SARS-CoV-2 infection? Medical Hypotheses 2022;162:110807. [DOI: 10.1016/j.mehy.2022.110807] [Reference Citation Analysis]
4 Özkan E, Celebi Ö, Keskin Ö, Gursoy A, Gürsoy-özdemir Y. Is Persistent Post-COVID Headache Associated With Protein-Protein Interactions Between Antibodies Against Viral Spike Protein and CGRP Receptor?: A Case Report. Front Pain Res 2022;3:858709. [DOI: 10.3389/fpain.2022.858709] [Reference Citation Analysis]
5 González-menacho J, Villas-roca M, Castañé H, Joven J, Camps J, Iftimie S. Can COVID-19 vaccines relieve severe tension-type headache and migraine? Medical Hypotheses 2022;161:110812. [DOI: 10.1016/j.mehy.2022.110812] [Reference Citation Analysis]
6 Hiroki CH, Sarden N, Hassanabad MF, Yipp BG. Innate Receptors Expression by Lung Nociceptors: Impact on COVID-19 and Aging. Front Immunol 2021;12:785355. [PMID: 34975876 DOI: 10.3389/fimmu.2021.785355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Caronna E, Pozo-Rosich P. Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research. Curr Pain Headache Rep 2021;25:73. [PMID: 34766205 DOI: 10.1007/s11916-021-00987-8] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
8 Abobaker A, Darrat M. Letter to the Editor From Abobaker and Darrat: "Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients". J Endocr Soc 2021;5:bvab052. [PMID: 34396020 DOI: 10.1210/jendso/bvab052] [Reference Citation Analysis]
9 Bolay H, Karadas Ö, Oztürk B, Sonkaya R, Tasdelen B, Bulut TDS, Gülbahar Ö, Özge A, Baykan B. HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism. J Headache Pain 2021;22:94. [PMID: 34384355 DOI: 10.1186/s10194-021-01306-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
10 Iannone LF, Geppetti P, Chiarugi A, De Cesaris F. COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report. Intern Emerg Med 2021. [PMID: 34118012 DOI: 10.1007/s11739-021-02787-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Khodabakhsh P, Asgari Taei A, Mohseni M, Bahrami Zanjanbar D, Khalili H, Masoumi K, Haji Abbas Shirazi A, Dargahi L. Vasoactive Peptides: Their Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets. Arch Med Res 2021:S0188-4409(21)00122-3. [PMID: 34134920 DOI: 10.1016/j.arcmed.2021.05.007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Ochoa-Callejero L, García-Sanmartín J, Villoslada-Blanco P, Íñiguez M, Pérez-Matute P, Pujadas E, Brody R, Oteo JA, Martínez A. Response to Letter to the Editor from Abobaker and Darrat: "Circulating levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients". J Endocr Soc 2021;5:bvab053. [PMID: 34396021 DOI: 10.1210/jendso/bvab053] [Reference Citation Analysis]